Pain Relief Snake Venom And Hemp

Cobra Venom (naja Naja) 4x, Hemp Extract (cannabis Sativa) 2x, Moccasin Venom (a.piscivorus) 6x


Green Earth Health Inc.
Human Otc Drug
NDC 73002-231
Pain Relief Snake Venom And Hemp also known as Cobra Venom (naja Naja) 4x, Hemp Extract (cannabis Sativa) 2x, Moccasin Venom (a.piscivorus) 6x is a human otc drug labeled by 'Green Earth Health Inc.'. National Drug Code (NDC) number for Pain Relief Snake Venom And Hemp is 73002-231. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Pain Relief Snake Venom And Hemp drug includes Agkistrodon Piscivorus Venom - 6 [hp_X]/mL Cannabis Sativa Subsp. Sativa Flowering Top - 2 [hp_X]/mL Naja Naja Venom - 4 [hp_X]/mL . The currest status of Pain Relief Snake Venom And Hemp drug is Active.

Drug Information:

Drug NDC: 73002-231
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Pain Relief Snake Venom And Hemp
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Cobra Venom (naja Naja) 4x, Hemp Extract (cannabis Sativa) 2x, Moccasin Venom (a.piscivorus) 6x
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Green Earth Health Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:AGKISTRODON PISCIVORUS VENOM - 6 [hp_X]/mL
CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP - 2 [hp_X]/mL
NAJA NAJA VENOM - 4 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 15 Sep, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 26 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Green Earth Health Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:X9V1Q8U150
8X454SZ22D
ZZ4AG7L7VM
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
73002-231-0128 mL in 1 BOTTLE, DROPPER (73002-231-01)15 Sep, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:


Product Elements:

Pain relief snake venom and hemp cobra venom (naja naja) 4x, hemp extract (cannabis sativa) 2x, moccasin venom (a.piscivorus) 6x anhydrous citric acid siraitia grosvenorii fruit tea leaf glycerin potassium sorbate water sodium benzoate ascorbic acid xanthan gum naja naja venom naja naja venom cannabis sativa subsp. sativa flowering top cannabis sativa subsp. sativa flowering top agkistrodon piscivorus venom agkistrodon piscivorus venom

Indications and Usage:

Indication: temporarily relieves pain associated with neuropathy, periodic neuralgia, neck and back pain.

Warnings:

Warnings: side effects might include headache, nausea, sore throat, allergic rhinitis, gastrointestinal discomfort, itchiness or mild rash. if symptoms persist or worsen, stop using this product and consult a physician. avoid contact with eyes. if product gets into eyes, flush with water, seek medical attention. if pregnant or breastfeeding, ask a health professional before use. if diagnosed with psychiatric or mood disorder, seek medical advice before use. keep out of reach of children.

Dosage and Administration:

Directions for use: • do not use if tamper proof cover is missing. • use graduated dropper to take 0.5 ml of liquid. • put the liquid directly into the mouth or under the tongue. • start using twice per day. use as needed thereafter to relieve discomfort. • allow several days for product to take maximum effect. • use within 60 days of opening. store at 50° to 75°f (10°c to 24°c).

Package Label Principal Display Panel:

Product label image description


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.